Outlook Therapeutics annual return on equity
2021
2022
Outlook Therapeutics Return on Equity (ROE) Growth & History (OTLK)
Outlook Therapeutics's return on equity was −989.99% for fiscal 2022.
View full Outlook Therapeutics company overviewOutlook Therapeutics annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2022 | 2022-09-30 | −989.99% | +440.34 pp |
| 2021 | 2021-09-30 | −1,430.33% | — |
Outlook Therapeutics quarterly return on equity
Q4.20
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q3 2023 | 2023-06-30 | −829.51% | −766.92 pp |
| Q2 2023 | 2023-03-31 | −50.71% | −4.23 pp |
| Q1 2023 | 2022-12-31 | −152.38% | −98.24 pp |
| Q4 2022 | 2022-09-30 | −99.55% | +54.90 pp |
| Q3 2022 | 2022-06-30 | −62.59% | +10.44 pp |
| Q2 2022 | 2022-03-31 | −46.48% | +211.11 pp |
| Q1 2022 | 2021-12-31 | −54.14% | — |
| Q4 2021 | 2021-09-30 | −154.46% | −10.58 pp |
| Q3 2021 | 2021-06-30 | −73.03% | — |
| Q2 2021 | 2021-03-31 | −257.59% | — |
| Q4 2020 | 2020-09-30 | −143.88% | — |
Outlook Therapeutics return on equity trends
Between the periods ended 2021-09-30 and 2022-09-30, Outlook Therapeutics's return on equity increased from −1,430.33% to −989.99%, a change of +440.34 percentage points. The latest reported quarter, Q3 2023, shows −829.51%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Outlook Therapeutics source filings ↗